EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiplex Microscopy Assay for Assessment of Therapeutic and Serum Antibodies against Emerging Pathogens

Nuno Sartingen, Vanessa Stürmer, Matthias Kaltenböck, Thorsten G Müller iD, Paul Schnitzler, Anna Kreshuk, Hans-Georg Kräusslich iD, Uta Merle iD, Frauke Mücksch iD, Barbara Müller iD, Constantin Pape iD, Vibor Laketa iD

Viruses · 2024

DOI: 10.3390/v16091473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Nuno Sartingen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral, Spike Glycoprotein, Coronavirus. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Infection Research, Deutsche Forschungsgemeinschaft, Deutsches Zentrum fuer Infektionsforschung (DZIF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of novel pathogens, exemplified recently by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the need for rapidly deployable and adaptable diagnostic assays to assess their impact on human health and guide public health responses in future pandemics. In this study, we developed an automated multiplex microscopy assay coupled with machine learning-based analysis for antibody detection. To achieve multiplexing and simultaneous detection of multiple viral antigens, we devised a barcoding strategy utilizing a panel of HeLa-based cell lines. Each cell line expressed a distinct viral antigen, along with a fluorescent protein exhibiting a unique subcellular localization pattern for cell classification. Our robust, cell segmentation and classification algorithm, combined with automated image acquisition, ensured compatibility with a high-throughput approach. As a proof of concept, we successfully applied this approach for quantitation of immunoreactivity against different variants of SARS-CoV-2 spike and nucleocapsid proteins in sera of patients or vaccinees, as well as for the study of selective reactivity of monoclonal antibodies. Importantly, our system can be rapidly adapted to accommodate other SARS-CoV-2 variants as well as any antigen of a newly emerging pathogen, thereby representing an important resource in the context of pandemic preparedness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Antibodies, ViralSpike Glycoprotein, CoronavirusHumansHeLa CellsAntigens, ViralMicroscopyCoronavirus Nucleocapsid ProteinsMachine LearningPhosphoproteins

Stichwörter der Autor:innen

SARS-CoV-2emerging pathogensmachine learningmonoclonal antibodiesmultiplex microscopyserology

Substanzen

Antibodies, ViralSpike Glycoprotein, CoronavirusAntigens, Viralspike protein, SARS-CoV-2Coronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2Phosphoproteins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
  • European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
  • German Center for Infection Research (DZIF), Partner Site Heidelberg, 69120 Heidelberg, Germany.
  • Department of Internal Medicine IV, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Institute of Computer Science, Göttingen University, 37073 Göttingen, Germany.
  • Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), Göttingen University, 37073 Göttingen, Germany.

ORCID-Profile: Thorsten G Müller, Hans-Georg Kräusslich, Uta Merle, Frauke Mücksch, Barbara Müller, Constantin Pape, Vibor Laketa

Förderung

  • German Center for Infection Research
  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum fuer Infektionsforschung (DZIF)
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy
  • Ministry of Science, Research and the Arts Baden-Württemberg, Germany

Zitieren

APA

Sartingen, N., Stürmer, V., Kaltenböck, M., Müller, T. G., Schnitzler, P., Kreshuk, A., Kräusslich, H. G., Merle, U., Mücksch, F., Müller, B., Pape, C., & Laketa, V. (2024). Multiplex Microscopy Assay for Assessment of Therapeutic and Serum Antibodies against Emerging Pathogens. Viruses. https://doi.org/10.3390/v16091473

Vancouver

Sartingen N, Stürmer V, Kaltenböck M, Müller TG, Schnitzler P, Kreshuk A, et al. Multiplex Microscopy Assay for Assessment of Therapeutic and Serum Antibodies against Emerging Pathogens. Viruses. 2024. doi:10.3390/v16091473

BibTeX
@article{Sartingen2024,
  author = {Sartingen, Nuno and Stürmer, Vanessa and Kaltenböck, Matthias and Müller, Thorsten G and Schnitzler, Paul and Kreshuk, Anna and Kräusslich, Hans-Georg and Merle, Uta and Mücksch, Frauke and Müller, Barbara and Pape, Constantin and Laketa, Vibor},
  title = {Multiplex Microscopy Assay for Assessment of Therapeutic and Serum Antibodies against Emerging Pathogens},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091473}
}
Kostenlos starten →